Joel Greenblatt - Gotham Asset Management
Holding/activity history for Syndax Pharmaceuticals, Inc. (SNDX)
← All SNDX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $12.99–22.73 · VW $16.88i | SEC | |
| 2025 Q3 | 48,246 | <0.01 | Buy | <0.01 | $8.59–17.24 · VW $13.48i | $742,265 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | 0.02 | $19.05–25.68 · VW $22.50i | SEC | |
| 2020 Q4 | 7,413 | 0.02 | Buy | 0.02 | $13.92–27.85 · VW $21.04i | $749,000 | SEC |
Price snapshot:
Current price$22.89
52-week low$9.03
52-week high$25.59